Syra Health reports Q3 2024 revenue $2.3M (+42% YoY); net loss narrows 69% sequentially to $417K

Syra Health Corp

2024-Q3 EPS reported -$0.48 vs consensus -$0.21 ▼ miss (-124.1%)

Revenue $2.3M, up 42% YoY from $1.6M; Population Health +36%, Healthcare Workforce +54%.
Net loss $417,535 ($0.06 EPS) vs $1.4M ($0.21) in Q2 2024, a 69% reduction quarter-over-quarter.
Gross margin improved to 29.7% from 17.8% in Q2 2024; operating expenses cut 37% sequentially.
Cash $2.7M with no long-term debt; management targets profitability in 2025.
Launched Syrenity mental health app; secured $5.8M Indiana training contract with revenue starting Q4 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.